NCT06906341 2026-04-14
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
Corcept Therapeutics
Phase 2 Recruiting
Corcept Therapeutics
University of Exeter
Massachusetts General Hospital
Arsenal Biosciences, Inc.